-
Product Insights
FutureLand – AEGEA City of Entertainment and the Arts First Phase – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our FutureLand - AEGEA City of Entertainment and the Arts First Phase - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
Aegea Biotechnologies Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Aegea Biotechnologies Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Aegea Biotechnologies Inc (Aegea) is a biotechnology company that discovers and develops reagents, research kits and in-vitro diagnostic (IVD) products for molecular analysis. Aegea is headquartered in San Diego, California, the US. GlobalData's Medical Devices company profile report, “Aegea Biotechnologies Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products....
-
Company Profile
Itausa SA – Company Profile
Itausa SA (Itausa) is a holding company with investments in financial services and industrial business areas. It offers financial services such as insurance, credit and financing, asset management, and investment banking services to wholesale and retail customers through Itau Unibanco. It mainly provides its products and services through its subsidiaries. Its portfolio of the companies include XP Inc, Alpargatas, Dexco, Copa Energia, NTS, and Aegea. The company has a stake in companies manufacturing and selling wood panels, bathroom porcelain, bathroom...
Add to Basket -
Product Insights
COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) are used to amplify and detect the specific nucleic acid sequences of SARS-CoV-2 virus at the point-of-care. The COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) pipeline market research report provides comprehensive information about the COVID 19 Point-of-Care (POC) Nucleic Acid Amplification Tests (NAATs) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Moreover, the report...
-
Product Insights
COVID 19 point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
COVID-19 point of care (POC) tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19. The COVID-19 POC tests pipeline products report provides comprehensive information about the COVID 19 point of care tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report also provides information on the pipeline products...
-
Product Insights
COVID 19 point of care (POC) Tests – Medical Devices Pipeline Assessment, 2020
COVID 19 Point of Care (POC) Tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19. GlobalData's Medical Devices sector report, “COVID 19 point of care (POC) Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the COVID 19 point of care (POC) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which...
-
Sector Analysis
Whole of Life Assurance – United Kingdom (UK) Protection Insurance 2020
Whole of life assurance accounts for the second-largest share of the protection market. The whole of life market grew in 2019. The majority of policies sold are guaranteed acceptance, and tend to be sold unadvised. Changes to electronic communications are bound to make it harder to reach out to potential customers. Meanwhile, independent financial advisors dominate the underwritten space. COVID-19 has led to delays in completing sales and has forced life insurers to tighten their underwriting guidelines. The market is...